Cover Image
市場調查報告書

全球流式細胞技術市場

Global Flow Cytometry Market

出版商 TriMark Publications 商品編碼 301482
出版日期 內容資訊 英文 166 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球流式細胞技術市場 Global Flow Cytometry Market
出版日期: 2016年03月28日 內容資訊: 英文 166 Pages
簡介

全球流式細胞技術市場,在生命科學、臨床診斷市場中是急速成長的市場區隔之一。目前的生命科學研究,在藥物研發及臨床診斷市場中,流式細胞技術對成長、創新而言帶來明亮的希望。

本報告提供全球流式細胞技術市場相關資料,包含市場規模,成長、技術平台、應用、新的計量儀器、產業趨勢及產業的內部結構等詳細內容分析,幹細胞研究,生物標記與搭配診斷,CD4檢驗,高通量篩檢及免疫、疫苗開發等極為富有魅力的成長領域的調查,美國及全球流式細胞技術產品的行銷,製造或開發企業分析,各地區的銷售資料檢討等。

第1章 概要

第2章 摘要整理

第3章 市場環境

  • 全球經濟的不確定性
  • 醫療的利用低
  • 生命科學研究的政府資金減少
  • 醫藥品產業的整合、CRO的外包
  • 對資源有限國家的全球性援助

第4章 流式細胞技術動的市場

  • 市場領導強化主導的地位
  • 全球流式細胞技術市場的趨勢
  • 全球流式細胞技術市場上成長機會
  • 策略性的討論事項

第5章 全球流式細胞技術市場

  • 全球流式細胞技術市場收益預測
  • 市場成長的促進要素
  • 市場阻礙成長要素

第6章 流式細胞技術的使用者

  • 醫藥品、生物科技、CRO
  • 臨床診斷
  • 大學、政府、私立財團
  • 應用科學

第7章 流式細胞技術市場競爭情形

  • 競爭企業、市場佔有率
  • 主要企業

第8章 全球流式細胞技術市場分析:各產品

  • 流式細胞技術的收益預測:各產品
  • 流式細胞技術設備的收益
  • 流式細胞技術的試劑、消耗品的收益預測
  • 流式細胞技術的軟體、生物資訊學開發者的收益預測

第9章 全球流式細胞技術市場分析:各地區

  • 流式細胞技術的收益預測:各地區
  • 北美的流式細胞技術市場
  • 西歐的流式細胞技術市場
  • 亞太地區的流式細胞技術市場
  • 新興高成長市場

第10章 資源有限的各國的POC流式細胞技術市場

第11章 近幾年的產業發展

第12章 流式細胞技術的用途

  • 調查用途
  • 臨床診斷
  • 醫藥品、生物醫藥品的藥物研發、開發
  • 全球健康
  • 應用科學

第13章 流式細胞技術技術

  • 流式細胞技術的原理
  • 液體工程
  • 光學
  • 電子產品
  • 資料分析
  • 細胞分類
  • 標籤、檢測
  • 多工為基礎的化驗
  • 影像流式細胞技術
  • 大量細胞計數法

第14章 新的流式細胞技術技術

  • 微流體工程流式細胞技術技術
  • 迅速CD4檢驗用技術

第15章 流式細胞技術的歷史

第16章 企業簡介

第17章 縮寫

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: TMRFLOW16-0301

Flow cytometry is a laboratory analytical technique that can rapidly measure multiple parameters of individual cells or particles as they pass through a beam of light, typically a laser. The global flow cytometry market remains one of the fastest-growing segments of life sciences and clinical diagnostics markets. In the current life sciences research, pharmaceutical drug discovery and development, and clinical diagnostics markets, flow cytometry offers some of the brightest promise for growth and innovation. The purpose of this TriMark Publications report is to provide a detailed analysis of the global flow cytometry market, including size, growth, technology platforms, applications, new instrumentation, industry trends and the internal structure of the sector. The study covers highly attractive growth areas such as stem cell research, biomarkers and companion diagnostics, CD4 testing, high throughput screening and immunology and vaccine development. It also analyzes almost all of the companies known to be marketing, manufacturing or developing flow cytometry products in the U.S. and worldwide. Additionally, this review provides detailed tables, charts and figures with past and projected sales data by geographic region for North America, Europe, Asia-Pacific and the emerging BRIC (Brazil, Russia, India and China) markets.

Table of Contents

1. Overview

  • 1.1 Statement of Report
  • 1.2 About This Report
  • 1.3 Scope of the Report
  • 1.4 Methodology

2. Executive Summary

  • 2.1 Global Flow Cytometry Market Projected to Reach $5.9 Billion by 2020
  • 2.2 Three Major Companies Command Over Half the Global Flow Cytometry Market
  • 2.3 Reagents and Consumables are the Fastest Growing Product Group
  • 2.4 Flow Cytometry will Advance Research and Development of New Cellular Therapies, Biologics and Vaccines
  • 2.5 There is an Urgent Need for Point of Care Flow Cytometry in Resource Limited Countries

3. Market Environment

  • 3.1 Global Economic Uncertainty
  • 3.2 Lower Healthcare Utilization
  • 3.3 Reduced Government Funding for Life Science Research
  • 3.4 Consolidation of the Pharmaceutical Industry and Outsourcing to CROs
  • 3.5 Global Aid to Resource Limited Countries

4. Flow Cytometry is a Dynamic Market

  • 4.1 Market Leaders Strengthen their Dominant Position
  • 4.2 Trends in the Global Flow Cytometry Market
    • 4.2.1 More Lasers, More Fluorescent Dyes, More Data
    • 4.2.2 Personal Flow Cytometers Moving Flow Cytometry Out of Core Laboratories
    • 4.2.3 High Throughput Screening and Clinical Diagnostic Flow Cytometry Driving Workflow Automation
    • 4.2.4 Portable POC Flow Cytometry Bringing CD4 Testing to Clinics and Remote Areas in Resource Limited Countries
    • 4.2.5 Cell Sorters are Scaled Up for Clinical Scale Cell Sorting
  • 4.3 Growth Opportunities in the Global Flow Cytometry Market
    • 4.3.1 Microfluidics, Next Generation Cell Analysis and Sorting
    • 4.3.2 Integrating Complementary Technologies Enable New Applications
    • 4.3.3 A Gap and Challenge for Computational Data Analysis
    • 4.3.4 High Growth Applications in Applied Markets Require Specialty Flow Cytometers
  • 4.4 Strategic Considerations
    • 4.4.1 The Flow Cytometry Market is Highly Competitive
    • 4.4.2 County to Country Dynamics Impact International Operations
    • 4.4.3 Governments are the Largest Funders of Life Science Research
    • 4.4.4 Reimbursement for Clinical Diagnostics Impacts Acceptance of New Tests

5. The Global Flow Cytometry Market

  • 5.1 Projected Global Flow Cytometry Market Revenue Through 2020
  • 5.2 Market Drivers
  • 5.3 Market Restrictors

6. Flow Cytometry Users

  • 6.1 Pharmaceutical, Biotechnology, CROs
  • 6.2 Clinical Diagnostic
  • 6.3 Academic, Government, Private Foundations
  • 6.4 Applied Science

7. Flow Cytometry Market Competitive Landscape

  • 7.1 Competitors and Market Share
  • 7.2 Key Players
    • 7.2.1 BD Biosciences
    • 7.2.2 Beckman Coulter
    • 7.2.3 Thermo Fisher Scientific
    • 7.2.4 Luminex Corporation
    • 7.2.5 MilliporeSigma
    • 7.2.6 Sysmex
    • 7.2.7 Miltenyi Biotec

8. Global Flow Cytometry Market Analysis by Product

  • 8.1 Projected Flow Cytometry Revenue by Product
  • 8.2 Projected Flow Cytometry Instrument Revenue
    • 8.2.1 Competitive Features of Flow Cytometry Instruments
    • 8.2.1.1 High Performance Multicolor Flow Cytometers
    • 8.2.1.2 Compact Flow Cytometers
    • 8.2.1.3 Handheld Flow Cytometers
    • 8.2.1.4 Cell Sorters
    • 8.2.1.5 Flow Cytometry Imaging Systems
    • 8.2.1.6 Mass Cytometry Systems
    • 8.2.1.7 Multiplex Bead Flow Cytometry Systems
    • 8.2.1.8 Flow Cytometry End-to-End Workflow Solutions
    • 8.2.1.9 Considerations when Purchasing a Flow Cytometry Instrument
  • 8.3 Projected Flow Cytometry Reagents and Consumables Revenue
    • 8.3.1 Selecting Flow Cytometry Reagents
    • 8.3.2 Leading Flow Cytometry Reagent Suppliers
  • 8.4 Flow Cytometry Software and Bioinformatics Developers

9. Global Flow Cytometry Market Analysis by Region

  • 9.1 Projected Flow Cytometry Market Revenue by Region
  • 9.2 North America Flow Cytometry Market
    • 9.2.1 North American Flow Cytometry Market Projected Revenue
    • 9.2.2 Research Segment
    • 9.2.3 Pharmaceutical and Biotechnology Segment
    • 9.2.4 Clinical Diagnostics Segment
  • 9.3 Western Europe Flow Cytometry Market
    • 9.3.1 Western Europe Flow Cytometry Market Projected Revenue
    • 9.3.2 Research Segment
    • 9.3.3 Pharmaceutical and Biotechnology Segment
    • 9.3.4 Clinical Diagnostics Segment
  • 9.4 Asia-Pacific Flow Cytometry Market
    • 9.4.1 Asia-Pacific Flow Cytometry Market Projected Revenue
    • 9.4.2 Research Segment
    • 9.4.3 Pharmaceutical and Biotechnology Segment
    • 9.4.4 Clinical Diagnostics Segment
  • 9.5 Emerging High Growth Markets
    • 9.5.1 Emerging High Growth Markets Projected Revenue
    • 9.5.2 China Flow Cytometry Market
    • 9.5.2.1 China Market Projected Revenue
    • 9.5.2.2 Research Segment
    • 9.5.2.3 Pharmaceutical and Biotechnology Segment
    • 9.5.2.4 Clinical Diagnostics Segment
    • 9.5.3 India Flow Cytometry Market
    • 9.5.3.1 India Market Projected Revenue
    • 9.5.3.2 Research Segment
    • 9.5.3.3 Pharmaceutical and Biotechnology Segment
    • 9.5.3.4 Clinical Diagnostics Segment
    • 9.5.4 Brazil Flow Cytometry Market
    • 9.5.4.1 Brazil Market Projected Revenue
    • 9.5.4.2 Research Segment
    • 9.5.4.3 Pharmaceutical and Biotechnology Segment
    • 9.5.4.4 Clinical Diagnostics Segment
    • 9.5.5 Russian Federation, Central and Eastern Europe Flow Cytometry Market

10. The POC Flow Cytometry Market in Resource Limited Countries

  • 10.1 Global Response to AIDS Epidemic Rapidly Increasing Demand for CD4 Testing
  • 10.2 Clinics in Rural Regions do not have CD4 Testing Capability
  • 10.3 Tiered Laboratory System in Resource Limited Countries
  • 10.4 The Flow Cytometry and POC Flow Cytometry Market Projected Revenue, 2015-2020
  • 10.5 The Global Flow Cytometry and POC Flow Cytometry Market by Region
    • 10.5.1 The Flow Cytometry and POC Flow Cytometry Market Revenue by Region
    • 10.5.2 South Africa POC Flow Cytometry Market
    • 10.5.3 Nigeria POC Flow Cytometry Market
    • 10.5.4 India POC Flow Cytometry Market
    • 10.5.5 China POC Flow Cytometry Market
    • 12.5.6 Russian Federation, Eastern Europe and Central Asia POC Flow Cytometry Market
    • 10.5.7 Latin America POC Flow Cytometry Market
  • 10.6 Competitors in the Flow Cytometry and POC Flow Market in Resource Limited Countries
    • 10.6.1 Competitor's Flow Cytometry Flow Cytometers and POC Flow Cytometry Analyzers

11. Recent Industry Developments, 2014-2016

12. Flow Cytometry Applications

  • 12.1 Research Applications
    • 12.1.1 Cell Signaling
    • 12.1.2 Cell Proliferation
    • 12.1.3 Cell Viability
    • 12.1.4 Apoptosis
    • 12.1.5 Cell Cycle Analysis
    • 12.1.6 Intracellular Ion Measurement
    • 12.1.7 Single Cell Gene Expression Analysis
    • 12.1.8 Immunology and Immunotherapy
    • 12.1.9 Stem Cell Research
    • 12.1.10 Microbiology
  • 12.2 Clinical Diagnostics
    • 12.2.1 Regulatory Control of Flow Cytometry Clinical Diagnostic Applications
    • 12.2.2 CD4 Lymphocyte Count
    • 12.2.3 Immunophenotyping Leukemias and Lymphomas
    • 12.2.4 Minimum Residual Disease
    • 12.2.5 Anti-Neutrophil Antibody Detection in Auto-Immune and Immunodeficiency Disease
    • 12.2.6 Platelet-Associated Immunoglobulin Assays
    • 12.2.7 Reticulocyte Count
    • 12.2.8 HLA Crossmatching and Cell Analysis for Stem Cell and Organ Transplantation
    • 12.2.9 Paroxysmal Nocturnal Hemoglobinuria
    • 12.2.10 Clinical Microbiology
  • 12.3 Pharmaceutical and Biopharmaceutical Drug Discovery and Development
    • 12.3.1 Drug Discovery and High Throughput Flow Cytometry
    • 12.3.2 Preclinical Toxicology and Safety
    • 12.3.3 Biomarkers and Drug Development
    • 12.3.4 GMP Manufacture of Biologicals
    • 12.3.5 Vaccine Development
  • 12.4 Global Health
    • 12.4.1 HIV/AIDS, Malaria, Tuberculosis
    • 12.4.2 Tropical Medicine
  • 12.5 Applied Sciences
    • 12.5.1 Marine and Environmental Biology
    • 12.5.2 Plant Biology
    • 12.5.3 Veterinary Medicine
    • 12.5.4 Food and Beverage Industry
    • 12.5.5 BioDefense

13. Flow Cytometry Technology

  • 13.1 Principle of Flow Cytometry
  • 13.2 Fluidics
  • 13.3 Optics
  • 13.4 Electronics
  • 13.5 Data Analysis
  • 13.6 Cell Sorting
  • 13.7 Labeling and Detection
  • 13.8 Multiplex Bead Assays
  • 13.9 Imaging Flow Cytometry
  • 13.10 Mass Cytometry

14. New Flow Cytometry Technology

  • 14.1 Microfluidics Flow Cytometry Technologies
  • 14.2 Technologies for Rapid CD4 Testing

15. History of Flow Cytometry

16. Company Profiles

  • 16.1 Abcam
  • 16.2 Alere, Inc.
  • 16.3 ALPCO Diagnostics
  • 16.4 Apogee Flow Systems
  • 16.5 Bangs Laboratories, a Division of Polysciences
  • 16.6 Bay Bioscience
  • 16.7 BD Biosciences (a Business Group within Becton Dickinson and Company (BD))
  • 16.8 Beckman Coulter (Business within Danaher)
  • 16.9 Bio-Rad Laboratories
  • 16.10 BioVision
  • 16.11 Cell Signaling Technology
  • 16.12 Cira Discovery Sciences
  • 16.13 Clarient Diagnostic Services, Inc.
  • 16.14 Cytobank, Inc.
  • 16.15 CytoBuoy, B.V
  • 16.16 CytonomeST
  • 16.17 Dako, an Agilent Technologies Company
  • 16.18 DeNovo Software
  • 16.19 Fluidigm Corporation
  • 16.20 Handyem
  • 16.21 IntelliCyt Corporation
  • 16.22 Luminex Corporation
  • 16.23 MBio Diagnostics
  • 16.24 MilliporeSigma (Division of Merck KGaA Germany)
  • 16.25 Miltenyi Biotec
  • 16.26 Orflow Technologies
  • 16.27 Sysmex
  • 16.28 PointCare Technologies
  • 16.29 Promega Corporation
  • 16.30 R&D Systems (Techne Corporation)
  • 16.31 Santa Cruz Biotechnology
  • 16.32 Soft Flow Hungary, Ltd.
  • 16.33 Sony Biotechnology, Inc.
  • 16.34 SouthernBiotech
  • 16.35 Spherotech
  • 16.36 Stratedigm
  • 16.37 TaKaRa Clontech
  • 16.38 Thermo Fisher Scientific
  • 16.39 Tree Star
  • 16.40 TTP LabTech
  • 16.41 Union Biometrica
  • 16.42 United States Biological Life Sciences
  • 16.43 Verity Software House

17. Acronyms Used in This Report

INDEX OF FIGURES

  • Figure 6.1: Flow Cytometry Market by Laboratory Type, 2015
  • Figure 7.1: Flow Cytometry Competitors' Market Share, 2015
  • Figure 8.1: Flow Cytometry Market Distribution by Product Revenue, 2015
  • Figure 8.2: Flow Cytometry Market Distribution by Product Revenue, 2020
  • Figure 8.3: Projected Flow Cytometry Revenue Growth by Product (CAGR), 2014-2020
  • Figure 9.1: Global Flow Cytometry Market Revenue by Region, 2015
  • Figure 9.2: Projected Flow Cytometry Market Revenue by Region, 2014-2020
  • Figure 9.3: Flow Cytometry Projected Growth Rate by Region, CAGR 2014-2020
  • Figure 9.4: Western Europe Flow Cytometry Market by Country, 2015
  • Figure 9.5: Emerging High Growth Countries Projected Flow Cytometry Revenue by Country, 2014-2020
  • Figure 9.6: Emerging Countries Flow Cytometry Revenue Share by Country, 2015
  • Figure 9.7: Emerging Countries Flow Cytometry Market Share by Country, 2020
  • Figure 10.1: CD4 Flow Cytometry Product Revenue Projection, 2014-2020
  • Figure 10.2: Flow Cytometry and POC Market Revenue by Region, 2015
  • Figure 10.3: Competitor's Share by Revenue, CD4 Flow Cytometry, 2015
  • Figure 10.4: Market Share, CD4 Counting Instruments in Middle- to Low-Income Countries, 2013
  • Figure 13.1: Schematic of a Flow Cell
  • Figure 13.2: Schematic of a Flow Cytometer Optical Layout
  • Figure 13.3: Example of a Dot Plot of Lysed Whole Blood
  • Figure 13.4: Fluorescence Intensity Histogram
  • Figure 13.5: Principle of Multiplex Bead Assay

INDEX OF TABLES

  • Table 5.1: Flow Cytometry Projected Market Revenue, 2014-2020
  • Table 5.2: Flow Cytometry Market Drivers
  • Table 5.3: Flow Cytometry Market Restrictors
  • Table 7.1: BD Biosciences Flow Cytometry Product Line
  • Table 7.2: BD Biosciences Flow Cytometry Branded Reagents
  • Table 7.3: Beckman Coulter Flow Cytometry Product Line
  • Table 7.4: Beckman Coulter Branded Flow Cytometry Kits and Reagents
  • Table 7.5: Thermo Fisher Scientific Flow Cytometry Reagents
  • Table 7.6: Thermo Fisher Scientific Flow Cytometry Instruments
  • Table 7.7: Luminex Instruments for Multiple Assay Analysis
  • Table 7.8: Luminex Branded Multiplex Assays and Reagents
  • Table 7.9: MilliporeSigma Flow Cytometry Platforms
  • Table 7.10: MilliporeSigma Flow Cytometry Instruments, Kits, Reagents
  • Table 7.11: Sysmex Partec Flow Cytometry Product Line
  • Table 7.12: Sysmex Partec Flow Cytometry Instruments
  • Table 7.13: Sysmex Partec Reagents and Kits
  • Table 7.14: Miltenyi Biotec Cell Separation Products
  • Table 7.15: Miltenyi Biotec Flow Cytometry Product Line
  • Table 8.1: Flow Cytometry Projected Revenue by Product, 2014-2020
  • Table 8.2: Suppliers of Flow Cytometry Instruments, Reagents and Software
  • Table 8.3: Features: High Performance Multicolor Flow Cytometers
  • Table 8.4: Compact Flow Cytometers
  • Table 8.5: Handheld Flow Cytometers
  • Table 8.6: Features: Cell Sorters
  • Table 8.7: Mass Cytometry Technology Features
  • Table 8.8: Multiplex Instrument Features
  • Table 8.9: Considerations when Selecting a Flow Cytometer
  • Table 8.10: Manufacturers of Flow Cytometry Antibodies, Fluorophores, Kits, Reagents, Sample Prep
  • Table 8.11: Flow Cytometry Software Developers
  • Table 9.1: Projected Flow Cytometry Market Revenue by Region, 2014-2020
  • Table 9.2: Flow Cytometry Projected Growth Rate by Region, CAGR 2014-2020
  • Table 9.3: North America Flow Cytometry Market Projected by Product, 2014-2020
  • Table 9.4: NIH Historical Appropriations, 2008-2016
  • Table 9.5: NIH Funding for Selected Disease Categories, 2016
  • Table 9.6: Flow Cytometry Systems in NIH Flow Cytometry Core Facilities
  • Table 9.7: CROs Specializing in Flow Cytometry Services
  • Table 9.8: Western Europe Flow Cytometry Market Projected by Product, 2014-2020
  • Table 9.9: Asia-Pacific Flow Cytometry Projected Market by Product, 20143-2020
  • Table 9.10: Emerging High Growth Countries Projected Flow Cytometry Revenue, 2014-2020
  • Table 10.1: Population of People Living with HIV/AIDS, 2014
  • Table 10.2: Projected Number of People Accessing ART Under the UNAIDS Fast-Track Strategy, 2014-2020
  • Table 10.3: Optimal Features of a POC CD4 Test
  • Table 10.4: Flow Cytometry and POC Flow Cytometry Market Revenue, 2014-2020
  • Table 10.5: CD4 Flow Cytometry Product Revenue Projection, 2014-2020
  • Table 10.6: CD4 Flow Cytometry and POC Cytometry Market Drivers and Restrictors
  • Table 10.7: Global Distribution of People Living with HIV by Country
  • Table 10.8: Flow Cytometry and POC Flow Cytometry Market Revenue by Region, 2015
  • Table 10.9: CD4 Platforms for Resource Limited Countries
  • Table 12.1: Cell Types, Proteins and Microbes Detected by Flow Cytometry
  • Table 12.2: Flow Cytometry Applications in Stem Cell Research
  • Table 12.3: Microorganisms Detected by Flow Cytometry
  • Table 12.4: Flow Cytometry Clinical Diagnostic Applications
  • Table 12.5: Advantages of Flow Cytometry for High Throughput Screening
  • Table 12.6: Flow Cytometry Applications for Preclinical Toxicology and Safety
  • Table 12.7: NIH Definition of Biomarkers
  • Table 12.7: Neglected Tropical Diseases
  • Table 12.8: Flow Cytometry Products for Applied Markets
  • Table 13.1: Common Fluorophores Used in Flow Cytometry
  • Table 15.1: Differences between Hematology Analyzers and Flow Cytometers
  • Table 15.2: Flow Cytometry Timeline
  • Table 20.1: List of Acronyms Used in this Report
Back to Top